Tag: biomedical
-

Toxic Neuro Protein Clearance Company Formed
A new enterprise is being formed to develop a device that clears from the nervous system toxic proteins associated with chronic and debilitating neurological disorders.
-

Govt. Shutdown Disrupts U.S. Science
Several agencies that run or finance labs are closed, due to the lapse of funding for about a quarter of federal departments that began on 22 December.
-

Antibiotic Prevents Staph Colonies in Newborns
Results from a clinical trial show a common antibiotic ointment can prevent dangerous staph bacteria from colonizing in vulnerable newborn infants.
-

FDA Clears Inhaled Parkinson’s Drug
A drug administered as an inhaled powder to supplement a common treatment for Parkinson’s disease received approval for marketing from the Food and Drug Administration.
-
Today’s Technologies Will Save And Enrich Lives In Childbirth
Technologies that are emerging today could go on to save and improve lives before they’ve even begun.
-

Eye Drops Reverse Infected Eye Scarring
Eye drops containing a therapeutic protein and applied as a gel, are shown in lab mice to remove scar tissue from the surface of infected or damaged corneas.
-

CDC Finds 12 People Sickened by Stem Cell Provider
Centers for Disease Control and Prevention issued a report on a provider of stem cell therapies indicating 12 people in 3 states were infected with bacteria from that company’s treatments.
-

Nanoscale Bacteria Particles Deliver Cancer Drugs
An engineering lab developed techniques for delivering cancer drugs into tumors in lab cultures and mice with nanoscale polymer particles, aided by a strain of salmonella bacteria.
-

FDA Warns Cord Blood-Stem Cell Company
Food and Drug Administration recently warned GeneTech Inc. that its unauthorized stem cell regenerative medicine products, may be causing serious blood infections.
-

Drug Discovery Start-Up Gains $400M Financing
A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank.